Back to search

Article

Abrogation of group III phospholipase A2 inhibits tumor growth and metastasis in ovarian cancer and promotes chemo-sensitization

2021-01-19

Abstract excerpt

<h4>Background: </h4> Aberrant lipogenicity and deregulated autophagy are common in most advanced human cancer and therapeutic strategies to exploit these pathways are currently under consideration. Group III Phospholipase A2 (sPLA2-III/PLA2G3), an atypical secretory PLA2, is recognized as a regulator of lipid metabolism associated with oncogenesis. Though recent studies reveal that high PLA2G3 expression signific...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f9e1bdc4-cc9f-597c-92ee-af15a4943a30
DOI
10.21203/rs.3.rs-147840/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Abrogation of group III phospholipase A2 inhibits tumor growth and metastasis in ovarian cancer and promotes chemo-sensitizationDOI 10.21203/rs.3.rs-147840/v1
Select a neighboring publication to make it the new centre.